Can a community program cut the time to treat psychosis?

NCT ID NCT05813457

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a program called PRESTO that aims to identify and treat first-episode psychosis sooner. The program educates the public, trains frontline workers like doctors and teachers, and provides a mobile team to connect patients to care. Researchers will measure whether this reduces the time a person goes untreated, which may improve their long-term outlook. The trial involves 416 participants across multiple centers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
PRESTO Early Identification Program (community education, training for frontline workers, and a mobile care team)
What this could lead to
If successful, this program could become a model for reducing delays in treating first-episode psychosis, potentially improving long-term outcomes for patients.
What could go wrong
This is a behavioral intervention study, not a drug trial. Results depend on community uptake and may not be easily replicated in other regions. The study is still recruiting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSYCHOTIC EPISODE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU de Montpellier

    RECRUITING

    Montpellier, 34090, France

  • CHU de Nîmes

    RECRUITING

    Nîmes, 30900, France

  • Chu Clermont-Ferrand

    RECRUITING

    Clermont-Ferrand, 63003, France

  • Chu Grenoble

    RECRUITING

    Grenoble, 38000, France

  • Chu Saint Etienne

    RECRUITING

    Saint-Etienne, 42100, France

  • Hospices Civils de Lyon

    RECRUITING

    Bron, 69500, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.